Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1981 1
1982 3
1983 2
1984 6
1985 4
1986 3
1987 1
1988 2
1989 6
1990 8
1991 7
1992 11
1993 8
1994 9
1995 8
1996 7
1997 5
1998 8
1999 16
2000 10
2001 16
2002 20
2003 28
2004 31
2005 33
2006 37
2007 29
2008 44
2009 68
2010 85
2011 72
2012 110
2013 115
2014 142
2015 143
2016 167
2017 155
2018 191
2019 198
2020 272
2021 320
2022 372
2023 335
2024 140

Text availability

Article attribute

Article type

Publication date

Search Results

2,900 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, Tsai TF, Gordon KB, Thaçi D, Zheng M, Hu N, Haeufel T, Thoma C, Lebwohl MG. Morita A, et al. Among authors: hu n. Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19. Lancet. 2023. PMID: 37738999 Clinical Trial.
White matter changes in Parkinson's disease.
Yang K, Wu Z, Long J, Li W, Wang X, Hu N, Zhao X, Sun T. Yang K, et al. Among authors: hu n. NPJ Parkinsons Dis. 2023 Oct 31;9(1):150. doi: 10.1038/s41531-023-00592-z. NPJ Parkinsons Dis. 2023. PMID: 37907554 Free PMC article. Review.
GABRG2 Variants Associated with Febrile Seizures.
Hernandez CC, Shen Y, Hu N, Shen W, Narayanan V, Ramsey K, He W, Zou L, Macdonald RL. Hernandez CC, et al. Among authors: hu n. Biomolecules. 2023 Feb 22;13(3):414. doi: 10.3390/biom13030414. Biomolecules. 2023. PMID: 36979350 Free PMC article.
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
Carbone DP, Ciuleanu TE, Schenker M, Cobo M, Bordenave S, Juan-Vidal O, Menezes J, Reinmuth N, Richardet E, Cheng Y, Mizutani H, Felip E, Zurawski B, Alexandru A, Paz-Ares L, Lu S, John T, Zhang X, Mahmood J, Hu N, De T, Santi I, Penrod JR, Yuan Y, Lee A, Reck M. Carbone DP, et al. Among authors: hu n. J Immunother Cancer. 2024 Feb 12;12(2):e008189. doi: 10.1136/jitc-2023-008189. J Immunother Cancer. 2024. PMID: 38346853 Free PMC article. Clinical Trial.
2,900 results